China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded the stock to ...

Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported fourth-quarter ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

The local gene-sequencing company and a U.S. clothing company face sales restrictions in China as part of that country’s ...

Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...

The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...